UTRADE brought to you by UOB Kay Hian

Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2021

DEC
0708091011121314151617181920212223242526
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price（HKD） BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
 6633QINGCI GAMES 06/12/202109/12/2021 16/12/2021 11.214.0 500 N/A 08/12/2021

CICC

CLSA

 -
2279YONGHE MEDICAL 01/12/202106/12/2021 13/12/2021 15.815.8 500 1.58% 03/12/2021

Morgan Stanley

CICC

Day 1：<25.73x

Day 2：<61.53x
2276CONANT OPTICAL 30/11/202109/12/2021 16/12/2021 4.466.10 500 N/A 08/12/2021

Guotai Junan

Day 1：>0x

Day 2：>0x

Day 3：>0x
2270DESUN SERVICES 30/11/202107/12/2021 17/12/2021 1.101.46 2,000 N/A 06/12/2021

Shenwan HongYuan

Day 1：>0x

Day 2：>0x

Day 3：>0x
9699SF INTRA-CITY 30/11/202107/12/2021 14/12/2021 16.4217.96 200 1.68% 06/12/2021

CICC

Merrill Lynch

Day 1：>0x

Day 2：>0x

Day 3：<1.97x
6821ASYMCHEM 30/11/202103/12/2021 10/12/2021 350.0410.0 100 N/A 02/12/2021

Goldman Sachs

CITIC

Day 1：>0x

Day 2：>0x

Day 3：>0x
1228CANBRIDGE-B 30/11/202103/12/2021 10/12/2021 12.1812.18 1,000 N/A 02/12/2021

Morgan Stanley

Jefferies

Day 1：>0x

Day 2：>0x

Day 3：<1.06x
2273GUSHENGTANG 30/11/202103/12/2021 10/12/2021 25.829.0 100 1.68% 02/12/2021

BofA

Haitong

Day 1：>0x

Day 2：>0x

Day 3：<1.12x
9898WB-SW 29/11/202102/12/2021 08/12/2021 388.0388.0 20 1.68% 01/12/2021

Goldman Sachs

UBS

CITIC

CICC

Day 1：>0x

Day 2：>0x

Day 3：>0x
Planned IPOs *
[Planned]
JL MAG RARE-EARTH Passed PHIP on 5 Dec N/A N/A N/A N/A N/A

CITIC*

BNP Paribas*

 -
[Planned]
China Tourism Group Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

CICC*

UBS*

 -
[Planned]
Shinsun Lifestyle Passed PHIP on 22 Nov N/A N/A N/A N/A N/A

ABCI*

CCBI*

 -
[Planned]
Horizon Construction Passed PHIP on 15 Nov N/A N/A N/A N/A N/A

Huatai*

Citi*

CMBI*

DBS*

 -
[Planned]
WEILONG Delicious Passed PHIP on 14 Nov N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

UBS*

 -
[Planned]
ZOINA Service Passed PHIP on 12 Nov N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
SenseTime 07/12/2021*2021-12-10 17/12/2021* 3.85*3.99* 1,000* N/A 09/12/2021*

CICC*

Haitong*

HSBC*

 -
[Planned]
TI Cloud Passed PHIP on 18 Oct N/A N/A N/A N/A N/A

CICC*

 -
[Planned]
IQIYI N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
FUTU N/A 2021* N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
Ximalaya N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Novotech Health Passed PHIP on 5 Sep N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

 -
[Planned]
Chervon 2021* N/A N/A N/A N/A N/A

CICC*

Citi*

 -
[Planned]
AInnovation Application Submitted* N/A N/A N/A N/A N/A

UBS*

CICC*

China Renaissance*

 -
[Planned]
Imeik Technology Dev N/A N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Edding Group Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

Credit Suisse*

 -
[Planned]
eBeauty Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

CITIC*

Credit Suisse*

 -
[Planned]
China Duty Free Group Application Suspended* N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Chief Group Application Submitted* N/A N/A N/A N/A N/A

BOCOM*

 -
[Planned]
Konew Financial N/A N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
LexinFintech N/A 2H21* N/A N/A N/A N/A

N/A

 -
[Planned]
Top Glove N/A Q3* N/A N/A N/A N/A

CICC*

 -
[Planned]
RF China Application Submitted* Q3* N/A N/A N/A N/A

ABCI*

CICC*

 -
[Planned]
Fangzhi Group Application Submitted* N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
Wanda Group N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
DRC Bank N/A Q3* N/A N/A N/A N/A

CMS*

CMBI*

ABCI*

ICBC*

 -
[Planned]
Hanyu Medical Passed PHIP on 13 Sep Q3* N/A N/A N/A N/A

CITIC*

Citi*

 -
[Planned]
XiaoDian N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
GOGOX N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Qdama N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Medbanks N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

 -
[Planned]
ESCO N/A Q4* N/A N/A N/A N/A

N/A

 -
[Planned]
APM Ｍonaco N/A 2021* N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Abbisko N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
NIO N/A 2021* N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

 -
[Planned]
YiSheng Biopharma Application Submitted* 2021* N/A N/A N/A N/A

Morgan Stanley*

Haitong*

 -
[Planned]
Novotech N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
ECARX N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

UBS*

 -
[Planned]
Betta Pharmaceuticals Passed PHIP on 30 May N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

 -
[Planned]
Visen Pharma N/A 2021* N/A N/A N/A N/A

Jefferies Group*

Morgan Stanley*

 -
[Planned]
Recbio N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Tencent Music N/A This Year* N/A N/A N/A N/A

Morgan Stanley*

JPMorgan*

 -
[Planned]
JOYY N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Vipshop N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
DiDi N/A 2022* N/A N/A N/A N/A

Goldman Sachs*

 -

# Terms and Conditions Apply

*Market News

：UOB Kay Hian (UOBKH) is one of the participants

Copyright ©, UOB Kay Hian (Hong Kong) Ltd. All rights reserved. Securities & Futures Commission Registered: CE Number AAW261 Client Agreement-Terms & Conditions ( Securities / Futures )